IceCure Medical (ICCM)

• Market cap: $67.7M
• 1 day: -0.76%
• 5 days: -4.32%
• 1 month: 20.18%
• 3 months: -0.45%
• 6 months: -25.9%
• Year to date: -19.88%
• 1 year: 56.43%
• 5 years: -90.96%
• 10 years: -90.96%
• Sector: Healthcare
• Industry: Medical Devices

About: Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.

Employees: 66

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

200% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 2

61% more capital invested

Capital invested by funds: $154K [Q1] → $247K (+$93.2K) [Q2]

29% more funds holding

Funds holding: 14 [Q1] → 18 (+4) [Q2]

0.2% more ownership

Funds ownership: 0.23% [Q1] → 0.43% (+0.2%) [Q2]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $2
• Avg. target: $2
• High target: $2

1 analyst rating

• positive: 1 100%
• neutral: 0 0%
• negative: 0 0%

HC Wainwright & Co. Yi Chen

$2

Buy Maintained

15 Aug 2025